Royal London Asset Management Ltd. Purchases 4,527 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Royal London Asset Management Ltd. grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 11.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 43,282 shares of the company’s stock after purchasing an additional 4,527 shares during the period. Royal London Asset Management Ltd. owned approximately 0.07% of Molina Healthcare worth $12,868,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Choreo LLC acquired a new position in shares of Molina Healthcare during the second quarter valued at about $226,000. Prudential PLC raised its holdings in shares of Molina Healthcare by 267.3% during the second quarter. Prudential PLC now owns 2,112 shares of the company’s stock valued at $628,000 after purchasing an additional 1,537 shares during the period. PFG Investments LLC raised its holdings in shares of Molina Healthcare by 21.6% during the second quarter. PFG Investments LLC now owns 827 shares of the company’s stock valued at $246,000 after purchasing an additional 147 shares during the period. Ashton Thomas Private Wealth LLC acquired a new position in shares of Molina Healthcare during the second quarter valued at about $40,000. Finally, Quest Partners LLC raised its holdings in shares of Molina Healthcare by 113,850.0% during the second quarter. Quest Partners LLC now owns 2,279 shares of the company’s stock valued at $678,000 after purchasing an additional 2,277 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on MOH. Truist Financial dropped their price objective on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a report on Monday, July 15th. Baird R W upgraded shares of Molina Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a report on Monday, July 29th. TD Cowen lowered their target price on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a report on Wednesday, July 24th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a report on Tuesday. One analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $378.00.

Molina Healthcare Trading Up 2.4 %

NYSE:MOH opened at $352.94 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. The firm has a market cap of $20.68 billion, a price-to-earnings ratio of 19.15, a price-to-earnings-growth ratio of 1.14 and a beta of 0.57. Molina Healthcare, Inc. has a 52 week low of $282.96 and a 52 week high of $423.92. The firm has a 50-day moving average price of $326.76 and a two-hundred day moving average price of $345.08.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating the consensus estimate of $5.73 by $0.13. The firm had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same quarter last year, the business posted $5.65 EPS. On average, equities analysts expect that Molina Healthcare, Inc. will post 23.5 earnings per share for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.